Gregor Karl Wenning conducted critical research into multiple system atrophy (MSA) and atypical Parkinsonian syndromes, fundamentally shifting clinical approaches to diagnosis and treatment. His work, which spanned experimental neurobiology and clinical practice, helped bridge the gap between biological mechanisms and patient care, establishing international standards for managing neurodegenerative disorders through a career anchored in Germany and academic collaboration.
Academic Formation
Born in Horstmar in 1964, Gregor Wenning pursued medicine at Wilhelms University in Muenster, completing his studies in 1991 with a doctorate earned summa cum laude. He expanded his expertise internationally, serving as a research fellow at the Institute of Neurology at Queen Square, London. In 1996, he obtained a PhD from University College London for a thesis examining the clinico-pathological and experimental aspects of multiple system atrophy.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Clinical Leadership in Innsbruck
Wenning joined the Innsbruck University Clinic in 1997, where he completed specialist training in neurology and psychiatry. In 2006, he was appointed Professor and Head of the Division of Clinical Neurobiology at the Medical University of Innsbruck. His tenure included the establishment of one of Austria's first tilt table laboratories in 2000, designed to diagnose neurocirculatory disturbances. In 2018, he took on the directorship of the university's Dysautonomia Center.
Advances in MSA Research
His primary scientific contributions focused on distinguishing MSA from other Parkinsonian syndromes. He successfully developed the first transgenic model for MSA, which replicated human disease progression through a combination of genetic factors and neurotoxic lesions. As the coordinator of the European MSA Study Group, he led a consortium of 24 research centres, later spearheading the first global research network dedicated to the condition.
Philosophical and Philanthropic Interests
Beyond neurobiology, Wenning engaged in philosophical study, focusing specifically on the works of Saint Augustine. His contributions to the field of neurodegeneration also included philanthropic initiatives. In 2015, he became president of the Bishop Dr. Karl Golser Foundation, which provides awards for research into atypical Parkinsonian disorders. He additionally served as president of the scientific advisory board for the US MSA Coalition starting in 2019.
Fast facts
- Born: 21 March 1964, Horstmar, Germany
- Died: 11 February 2024
- Education: PhD, University College London, 1996
- Field: Neurology and Neurobiology
- Key focus: Multiple system atrophy (MSA)
- H-index: 104
- Notable role: President, Bishop Dr. Karl Golser Foundation
- Academic post: Professor, Medical University of Innsbruck
Questions readers ask
What was Gregor Wenning's primary contribution to medicine?
He developed the first transgenic model for multiple system atrophy and helped clarify diagnostic distinctions between MSA and Parkinson's disease.
What subjects did Wenning study outside of medicine?
He pursued philosophical works, focusing specifically on the writings of Saint Augustine.
Achievements
- Fields: neurodegeneration, Parkinson's disease and neurobiology
